News from 23andMe
Stay current with all the latest and breaking news about 23andMe, compare headlines and perspectives between news sources on stories happening today. In total, 33 stories have been published about 23andMe which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top 23andMe News
Latest News Stories
23andMeWojcicki wrote the company would be better positioned "outside of the short term pressures of the public markets."Cindy Ord/VF24/Getty Images23andMe's board resigned over a 'distracting difference of view' with cofounder Anne Wojcicki.The board rejected an earlier proposal by Wojcicki to take the company private.Wojcicki told employees she was 'surprised and disappointed' by the resignations.23andMe's entire board of directors resigned from the …See the Story
Read the memo 23andMe's cofounder sent to staff after the entire board quit
100% Left coverage: 1 sources
23andMe23andMe, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 billion. Then its fortunes began to sink. Fading interest in DNA kits – 23andMe’s main product – was one driver. So was news last year that hackers stole ancestry data on 6.9 […] © 2024 TechCrunch. All rights reserved. For personal use only.See the Story
23andMe sees independent board directors quit en masse
100% Center coverage: 1 sources
23andMe · CaliforniaAll seven independent directors of 23andMe's board have immediately resigned, they wrote in a public letter Tuesday, expressing concerns over their differing views with CEO Anne Wojcicki. The chief executive and co-founder remains as the sole board member amid a monthslong attempt to take the struggling startup private. The departingSee the Story
All of 23andMe's independent board members resign over disagreements with CEO
23andMeSeptember is Sickle Cell Awareness Month, which offers us another chance to highlight some of the work 23andMe and its collaborators have done over the years. Earlier this month, researchers from 23andMe, the the National Institutes of Health, and Johns Hopkins University School of Medicine published new data on the association between sickle cell trait and blood clots. The new findings highlight the importance of this ongoing research and our o…See the Story
Learn More About Our Research and Collaborations During Sickle Cell Awareness Month
23andMe · BarcelonaBARCELONA — A month after gutting its internal drug discovery group, 23andMe is trudging along with the experimental medicines it’s already brought into the clinic. 23andMe has struggled with its dual identity as a human genetics company and drug R&D outfit. It’s now getting into the GLP-1 arena, and itsSee the Story
23andMe heads to ESMO to tout its two clinical-stage drugs after scrapping discovery team
23andMe · CaliforniaBiotechnology company 23andMe has agreed to pay a $30 million settlement over a massive data breach that affected 6.9 million users. Per Reuters, the genetic testing company filed a court document on Thursday detailing the settlement in a class action lawsuit in the Northern District of California. In the document, 23andMe proposed compensation for victims of the data breach.
SEE ALSO:
23andMe confirms how many people were affected by its data…See the Story
23andMe breach victims to benefit from multi-million dollar settlement
100% Left coverage: 1 sources
